I'm kind of late to the party, but I figured I would offer my two cents (probably only worth one and a half in today's stock market) on Michigan Reps. John Dingell and Bart Stupak questioning of Dr. Robert Jarvik's credentials and his role as pitchman for the drug Lipitor.
In case any of you missed it, the Wall Street Journal just published a moving piece (click here to read) on pharma layoffs and their impact on the individual, in particular the chemists behind the small molecule drug. The article examines layoffs at Ann Arbor, Mich.
Yesterday, news came that Pfizer has asked the government to rescind its report on the Trovan clinical trials, subject of criminal and civil lawsuits. The company alleges the report was biased. Today, three alleged victims asked that they be included among the plaintiffs, and pleaded with the court to dismiss...
Pfizer announced this morning that the last of its UK plants will close with the Sandwich manufacturing operations in east Kent. The decision brings an end to 53 years of manufacturing history at the plant, and will leave 420 without jobs.
More sad news on pharma's restructuring. One comment from an anonymous insider: "American Home Products has gone from a headcount of over 7,000 to about 750. This has to be a first." And, unfortunately, insiders believe that this is only the beginning.
It's pretty challenging to keep up with new developments the "Trovan" clinical trials case in Nigeria, where Pfizer faces four separate lawsuits, two in Kano, the state where the trials took place, and two federal suits.
The Associated Press reports that the Nigerian government has withdrawn its original Trovan lawsuit and added a fraud charge. Government spokesmen allege that they have uncovered evidence suggesting that Pfizer bypassed company rules requiring family consent before beginning experimental treatments.
Click here to watch Bloomberg's latest update. Lipitor weakness was a key factor in lower sales figures, the company says. CEO Kindler's remarks shone a brief, if unaccustomed spotlight on manufacturing, with an emphasis on the need to improve product life cycle management, something that experts agree the industry as...
BBC reports today that Nigeria's Abuja court has refused to allow 85 new claims to be added to the original 54, in the state's lawsuit against Pfizer, which is accused of conducting improper drugs trials on children.
As Pfizer investigates the marketing of its new HIV drug Maraviroc, Pharmalot has learned that the company's other HIV treatment, Viracept, may also have been improperly marketed. An insider within the company has provided information, and claims that he is being given the treatment that most whistleblowers receive. An excerpt: "...